Provided by Tiger Fintech (Singapore) Pte. Ltd.

CVS Health

65.57
+0.12000.18%
Pre-market: 65.05-0.5200-0.79%08:08 EDT
Volume:10.83M
Turnover:710.09M
Market Cap:82.77B
PE:17.92
High:66.43
Open:65.52
Low:64.83
Close:65.45
Loading ...

Pre-Bell|U.S. Futures Slip; Tesla Gains 1%; XPeng Jumps 3%; PVH Surges 16%; Newsmax Soars Another 30%

Tiger Newspress
·
01 Apr

U.S. Stocks to Watch: Tesla, XPeng, PVH, Nvidia, Strategy, Coinbase, Newsmax, and More

Dow Jones
·
01 Apr

CVS Health and Deckers Are the S&P 500's Best and Worst for the Quarter. Here's Why. -- Barrons.com

Dow Jones
·
01 Apr

Jim Cramer on CVS Health (CVS): “A Comeback Story with New Management!”

Insider Monkey
·
31 Mar

The Hartford expands Pannala and Hawkins' roles after Soni exits

Reuters
·
31 Mar

The 3 Best Performing S&P 500 Stocks of 2025 Q1

Zacks
·
31 Mar

Here’s What Dragged CVS Health Corp. (CVS) in Q4

Insider Monkey
·
31 Mar

CVS Health Corporation (NYSE:CVS) is a favorite amongst institutional investors who own 84%

Simply Wall St.
·
30 Mar

Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?

Zacks
·
28 Mar

The Zacks Analyst Blog Highlights CVS Health, Ulta Beauty, Progressive, AMD and Citigroup

Zacks
·
28 Mar

Top Women-Run Company Stocks to Enrich Your Portfolio

Zacks
·
27 Mar

Why the Market Dipped But CVS Health (CVS) Gained Today

Zacks
·
27 Mar

CVS Health Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Mar

Is CVS Health Corporation (CVS) The Best Healthcare Dividend Stock to Invest in?

Insider Monkey
·
24 Mar

Jefferies Sticks to Its Hold Rating for CVS Group plc (CVSG)

TIPRANKS
·
23 Mar

Piper Sandler Adjusts Price Target on CVS Health to $74 From $72, Maintains Overweight Rating

MT Newswires Live
·
21 Mar

CVS Health Is Maintained at Overweight by Piper Sandler

Dow Jones
·
21 Mar

CVS Health Corp : Piper Sandler Raises Target Price to $74 From $72

THOMSON REUTERS
·
21 Mar

Q4 2024 ARS Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
21 Mar

CVS Health Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
21 Mar